| 英文名稱 | 中文名稱 | CAS | MF |
|
PATENTBLUEVEXTRA
|
|
|
|
|
PATENT BLUE 7BA
|
|
|
|
|
PATENT BLUE VF HI
|
|
|
|
|
PATENT BLUE GG
|
|
|
|
|
Isosulfan Blue
|
異硫藍(lán)
|
68238-36-8
|
C27H31N2NaO6S2
|
|
PATENT BLUE V
|
專利藍(lán) V
|
3536-49-0
|
C27H34CaN2O7S2
|
|
PATENT BLUE A, AF
|
|
|
|
|
PATENT BLUE V(CRM STANDARD)
|
|
|
|
|
PATENT BLUE V IBP(CRM STANDARD)
|
|
|
|
|
PatentblueV
|
五號專利蘭
|
|
C54H61CaN4O14S4
|
|
patensin
|
|
|
|
|
PATENTFUELWORKERS
|
|
|
|
|
PbI2(1,10-phen)
|
1,10-鄰菲啰啉二碘化鉛
|
|
|
|
2-(P-BIPHENYL)ISOPROPYLOXYCARBONYL HYDRAZIDE
|
|
18597-92-7
|
C16H18N2O2
|
|
P-BIPHENYL THIOPHENOL
|
|
|
|
|
PATERNALSMOKING
|
|
|
|
|
4-(p-Biphenylyl)-3-hydroxybutyric acid
|
4(P-聯(lián)苯基)-3-羥丁酸
|
6845-17-6
|
C16H16O3
|
|
p-Biphenylbutylene oxide
|
|
61396-61-0
|
C16H16O
|
|
p-Biphenyldiol, tetrabromo-
|
|
58781-88-7
|
|
|
P-BIPHENYLOXY ETHYL ACRYLATE
|
|
|
C17H16O3
|
|
PATERSON PROCLENS SPRAY
|
|
|
|
|
P-BIPHENYLOXY ETHYL METHACRYLATE
|
|
|
C18H18O3
|
|
3-(p-Biphenylyl)-5-methyl-2-phenyl-2H-tetrazolium chloride
|
|
|
C20H19ClN4
|
|
PASOTE
|
|
|
|
|
PA(soybeanPC)NH4+salt
|
磷脂酸銨鹽
|
475995-54-1
|
|
|
Pas2 protein
|
|
149290-40-4
|
|
|
pas3 protein
|
|
139247-58-8
|
|
|
pas8 protein
|
|
|
|
|
PAS5 protein
|
|
|
|
|
PA11S (Proteasome Activator 11S, Subunit REG gamma)
|
|
|
|
|
PA11S (Proteasome Activator 11S, Subunit REG alpha)
|
|
|
|
|
PAS1 protein
|
|
|
|
|
PAS10 protein
|
|
|
|
|
Pas protein
|
|
|
|
|
Pathalic anhydride
|
|
|
C8H4O3
|
|
PATHARCHUR
|
|
|
|
|
pas-related protein 6
|
|
|
|
|
pasresin B
|
|
78515-79-4
|
|
|
pas-related protein 7
|
|
|
|
|
PCA 10
|
|
102135-82-0
|
|
|
PCA 16
|
|
128864-45-9
|
C25H44N3O10P
|
|
PCA
|
膦基聚羧酸 PCA
|
71050-62-9
|
(C3H4O2.H3O2P.Na)x
|
|
PCA-9
|
|
16870-86-3
|
C13H13ClN4
|
|
PAS-2 salt solution
|
|
|
|
|
p-(Bis(2-bromoethyl)amino)phenol
|
|
21667-05-0
|
C10H13Br2NO
|
|
p-(Bis(2-bromoethyl)amino)phenol o-methylbenzoate
|
|
21667-02-7
|
C18H19Br2NO2
|
|
5-(p-(Bis(2-bromoethyl)amino)anilino)-2,4-dinitrobenzamide
|
|
32869-03-7
|
C17H17Br2N5O5
|
|
p-(Bis(2-bromoethyl)amino)phenol m-methoxybenzoate
|
|
22954-19-4
|
|
|
p-[Bis(2-bromoethyl)amino]phenyl=4-biphenylcarboxylate
|
|
22953-45-3
|
C23H21Br2NO2
|
|
p-[Bis(2-bromoethyl)amino]phenyl=m-chlorobenzoate
|
|
22954-17-2
|
C17H16Br2ClNO2
|
|
p-[Bis(2-chloroethyl)amino]hydrocinnamic acid
|
|
6746-11-8
|
C13H17Cl2NO2
|
|
4-[p-Bis(2-chloroethyl)aminophenyl]amino-1(4H)-naphthalenone
|
|
63979-13-5
|
C20H18Cl2N2O
|
|
p-[Bis(2-chloroethyl)amino]phenyl=m-bromobenzoate
|
|
22953-52-2
|
C17H16BrCl2NO2
|
|
3-[[p-[Bis(2-chloroethyl)amino]phenyl]azo]-1,5-naphthalenedisulfonic acid
|
|
|
C20H19Cl2N3O6S2
|
|
1-[p-[Bis(2-chloroethyl)aminomethyl]phenyl]azo-2-naphthol
|
|
|
C21H21Cl2N3O
|
|
p-[Bis(2-chloroethyl)amino]carbanilic acid isopropyl ester
|
|
2045-44-5
|
C14H20Cl2N2O2
|
|
p-[Bis(2-chloroethyl)amino]phenyl=p-bromobenzoate
|
|
22953-53-3
|
C17H16BrCl2NO2
|
|
6-[p-Bis(2-chloroethyl)aminophenyl]azo-2-naphthalenesulfonic acid
|
|
|
C20H19Cl2N3O3S
|
|
2-(1-(4-(p-bis(2-chloroethyl)-aminophenyl)-butanoyloxy)methyl)-1,4-dihydroxy-9,10-anthraquinone
|
|
|
C29H27Cl2NO6
|
|
p-(Bis(2-chloroethyl)amino)phenethylamine
|
|
58880-18-5
|
C12H18Cl2N2
|
|
2-(1-(4-(p-bis(2-chloroethyl)aminophenyl)-butanoyloxy)ethyl)-1,4-dihydroxy-9,10-anthraquinone
|
|
|
C30H29Cl2NO6
|
|
P-BIS(2-CHLORO-1,1-DIMETHYLETHYL)BENZENE
|
|
|
C14H20Cl2
|
|
4-[[p-[Bis(2-chloroethyl)amino]phenyl]iminomethyl]-5-hydroxy-6-methyl-3-pyridinemethanol
|
|
|
C18H21Cl2N3O2
|
|
2-[p-[Bis(2-chloroethyl)amino]phenyl]-N-ethylacetamide
|
|
40068-20-0
|
C14H20Cl2N2O
|
|
p-[Bis(2-chloroethyl)amino]phenyl=m-chlorobenzoate
|
|
22953-54-4
|
C17H16Cl3NO2
|
|
p-[3-[Bis(2-chloroethyl)amino]-4-methylphenylcarbonylamino]benzenesulfonyl fluoride
|
|
|
C18H19Cl2FN2O3S
|
|
5-[p-[Bis(2-chloroethyl)amino]phenyl]valeric acid
|
|
64508-90-3
|
C15H21Cl2NO2
|
|
p-[[bis[4-(dimethylamino)phenyl]methyl]amino]benzenesulphonic acid
|
|
47654-02-4
|
C23H27N3O3S
|
|
P-BIS(DIMETHYLMETHOXYSILYL)BENZENE
|
1,4-二(甲氧二甲基硅烷基)苯
|
131182-68-8
|
C12H22O2Si2
|
|
PATHONORMCONTROLSERAHIGH
|
|
|
|
|
pathogen-elicited epithelial chemoattractant
|
|
|
|
|
pathogenesis-related proteins
|
|
|
|
|
pathogen-induced protease, P69
|
|
|
|
|
pathogenesis-related protein P14a
|
|
|
|
|
pathogenicity protein, Xanthomonas
|
|
139735-78-7
|
|
|
patientoside B
|
|
|
|
|
pathogen-induced oxygenase
|
|
|
|
|
patientoside A
|
|
|
|
|
PATHOLOGISTS
|
|
|
|
|
PASSELLI
|
|
|
|
|
p-bis(epoxyethyl)benzene
|
1,4-二(環(huán)氧乙烷-2-基)苯
|
16832-58-9
|
C10H10O2
|
|
PATIENCE DOCK ROOT PLANT EXTRACT
|
|
|
|
|
PATHONORMCONTROLSERALOW
|
|
|
|
|
3-[p-[Bis(2-fluoroethyl)amino]phenyl]propanoic acid
|
|
|
C13H17F2NO2
|
|
4-[p-[Bis(2-fluoroethyl)amino]phenyl]butyric acid
|
|
|
C14H19F2NO2
|
|
3-[p-[Bis(2-fluoroethyl)amino]phenyl]propenoic acid
|
|
4093-13-4
|
|
|
p-[[4-[bis(2-hydroxyethyl)amino]-o-tolyl]azo]-N-(2-chloroethyl)benzenesulphonamide
|
對[[4-[二(2-羥基乙基)氨基]-鄰甲苯基]偶氮]-N-(2-氯乙基)苯磺酰胺
|
14607-25-1
|
C19H25ClN4O4S
|
|
Hydroquinone bis(2-hydroxyethyl)ether
|
對苯二酚二羥乙基醚
|
104-38-1
|
C10H14O4
|
|
Passion Seed Oil
|
|
|
|
|
Passionfiowe Herb Extract
|
|
|
|
|
Passion flower (flower)
|
|
|
|
|
PASSIONFRUIT FLAVOUR
|
|
|
|
|
PASSIVIERUNGSMITTEL
|
|
|
|
|
Passicapsin
|
|
82829-54-7
|
C18H27NO10
|
|
PassionFlowerP.E.4:1,PassifloraIncarnate
|
|
|
|
|
PassionflowerHerb
|
|
|
|
|
PassionFlowerP.E.10:1,PassifloraIncarnate
|
|
|
|
|
Passionflower powder
|
|
|
|
|
Passionflower
|
西番蓮
|
|
|
|
PASSIFLORA EDULIS SEED OIL
|
雞蛋果(PASSIFLORA EDULIS)籽油
|
97676-26-1
|
|